首页|期刊导航|中医药临床杂志|基于网络药理学、分子对接和实验验证探究山楂-泽泻药对治疗高甘油三酯血症的作用机制

基于网络药理学、分子对接和实验验证探究山楂-泽泻药对治疗高甘油三酯血症的作用机制OA

Investigating the Mechanism of Action of Hawthorn-Alisma Herbal Extract in Treating Hypertriglyceridemia Based on Network Pharmacology,Molecular Docking,and Experimental Verification

中文摘要英文摘要

目的:基于网络药理学、分子对接和体外实验,系统探究山楂-泽泻药对治疗高甘油三酯血症的作用机制.方法:通过传统中药系统药理学数据库和分析平台和中医药整合药理学研究平台 2.0 获取山楂和泽泻的潜在活性成分及其作用靶点,利用 GeneCards 数据库检索与高甘油三酯血症相关靶点,利用 Cytoscape 3.7.2 软件构建"活性成分-靶点-疾病"网络;将 2 者共有的靶点输入 STRING 数据库,得到蛋白质-蛋白质相互作用网络;通过富集分析 R 包clusterProfiler 进行 GO 功能富集分析及 KEGG 通路富集分析;通过 AutodockVina 1.2.2 进行分子对接验证;选取结合能力较好的 6 个中药单体进行实验验证,构建 AML-12 高脂细胞模型,探究中药单体对高脂细胞模型脂滴沉积及脂解能力的影响.结果:山楂-泽泻药对经过筛选得到 19 个潜在活性成分和 246 个潜在作用靶点,其中与高甘油三酯血症共同作用靶点有 94 个.GO 功能富集分析发现山楂-泽泻药对治疗高甘油三酯血症主要与对脂多糖的反应、基因转录与表达等相关.KEGG 通路富集分析发现其主要与流体剪切应力和动脉粥样硬化通路、糖尿病并发症AGE-RAGE 信号通路等相关.分子对接结果显示,主要活性成分山柰酚、槲皮素、泽泻醇 B、泽泻醇 B 乙酸酯、泽泻醇 C 乙酸酯及泽泻醇 B 醋酸酯与多个通路分子有较强的结合力.实验结果显示,泽泻醇 B、山柰酚和泽泻醇 C 乙酸酯能够显著减少高脂细胞脂滴沉积,调控甘油三酯脂肪酶增强脂解能力.结论:山楂-泽泻药对通过多成分、多靶点、多通路协同作用治疗高甘油三酯血症,为山楂-泽泻药对的降脂机制和临床合理应用提供了理论依据与实验支持.

Objective:To systematically explore the mechanism of action of hawthorn-Alisma herb in the treatment of hypertriglyceridemia based on network pharmacology,molecular docking and in vitro experiments.Methods:Poten-tial active ingredients and their targets of hawthorn and alisma were obtained using a traditional Chinese medicine sys-tems pharmacology database and analysis platform and a TCM integrated pharmacology research platform 2.0.Targets related to hypertriglyceridemia were retrieved from the Gene Cards database,and an"active ingredient-target-disease"network was constructed using Cytoscape 3.7.2 software.Common targets from both were input into the STRING data-base to obtain a protein-protein interaction network.GO functional enrichment analysis and KEGG pathway enrich-ment analysis were performed using the R package clusterProfiler.Molecular docking verification was performed using Autodock Vina 1.2.2.Six monomers of traditional Chinese medicine with good binding ability were selected for experi-mental verification.An AML-12 hyperlipidemic cell model was constructed to investigate the effects of the monomers of traditional Chinese medicine on lipid droplet deposition and lipolysis in the hyperlipidemic cell model.Results:The hawthorn-alisman pair was screened and identified 19 potential active ingredients and 246 potential targets,of which 94 were co-targets of hypertriglyceridemia.GO functional enrichment analysis revealed that the hawthorn-alisman pair's treatment of hypertriglyceridemia is mainly related to its response to lipopolysaccharide,gene transcription,and expression.KEGG pathway enrichment analysis showed that it is mainly related to fluid shear stress and atherosclerosis pathways,as well as the AGE-RAGE signaling pathway in diabetic complications.Molecular docking results showed that the main active ingredients,kaempferol,quercetin,alismol B,alismol B acetate,alismol C acetate,and alismol B acetate,have strong binding forces with multiple pathway molecules.Experimental results showed that alismol B,kaempferol,and alismol C acetate can significantly reduce lipid droplet deposition in hyperlipidemia cells and regu-late triglyceride lipase to enhance lipolysis.Conclusion:The hawthorn-Alisma herbal pair treats hypertriglyceridemia through synergistic effects involving multiple components,targets,and pathways,providing theoretical basis and exper-imental support for the lipid-lowering mechanism and rational clinical application of the hawthorn-Alisma herbal pair.

罗文涓;黄伟;吴咏姿;姚林波;刘诗雨;冷玉琳;刘婷婷;夏庆;金涛;杨鑫敏

四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041||四川大学华西医院生物样本库 四川 成都 610041||四川大学疾病分子网络前沿科学中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041成都中医药大学附属医院 四川 成都 610072四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041四川大学华西医院中西医结合中心华西胰腺炎卓越中心 四川 成都 610041

医药卫生

山楂泽泻高甘油三酯血症网络药理学分子对接实验验证

HawthornAlismahypertriglyceridemiaNetwork pharmacologyMolecular dockingExperimental ver-ification

《中医药临床杂志》 2026 (6)

1181-1191,11

国家自然科学基金青年项目(82304985)四川省自然科学基金项目(青年基金)(2025ZNSFSC1794,2025ZNSFSC1797)四川省中医药管理局——重症急性胰腺炎中医药疗效再突破创新团队(2023ZD04)

10.16448/j.cjtcm.2026.0622

评论